KarboLyn Study Data
Re: IRB No : 29443/1; KL-001
Study: July 2014–March 2015
The Clinical Study sought to document whether or not KarboLyn has a positive and sustainable impact on blood sugar levels in normal adults during aerobic activity. A total of 24 male and female adults were randomized to receive 50 grams of either KarboLyn or a sugar drink (dextrose). Blood was drawn before and during the two hour study, according to the protocol, and physiological responses were recorded.
Data Obtained From Participants Indicated that a simple sugar promoted a steep drop and subsequent “crash” (defined as a drop of more than 10 points or greater than 1 mg/dl of glucose per minute, or more) at a predictable point in time.
KarboLyn gave an overall smoother decline in blood glucose level. This decline was not perceived by the volunteers as a “crash”.
This study was funded by a Grant from the Montana Board of Research and Commercialization Technology.